That Dragon, Cancer

Numinous Games · 2016 · $9.99 · Adventure · deal grade B

Measured on 2026-10-05 07:18 UTC. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

Estimated net residual revenue: $189 to $283 per month
Opportunity: $449 per month at x1.90 dormancy
Estimated lifetime owners: 89.2k
90% positive across 1561 reviews · 4.4 reviews/month

Why it's flagged

Developer silent for 10.7 years
Studio inactive: no public activity across 1 tracked titles
Store page localized in only 1 language(s)

Analyst notes (AI-assisted)

Note written 2026-09-15; the live figures above take precedence over any numbers in it.

A narrative-driven adventure about a family's journey through their young son's terminal cancer diagnosis, released in 2016 by Numinous Games.

That Dragon, Cancer sits in a rare category: a deeply personal, critically acclaimed indie title with sustained positive sentiment (90%+) that generates modest but consistent residual revenue despite zero promotional activity in over a year. The title has minimal commercial appeal to traditional acquirers, but represents a durable emotional asset with lingering cultural relevance; it may warrant consideration only by publishers committed to preserving meaningful work or by rights-management firms evaluating catalog longevity. For most buyers, the modest monthly cash flow and dormant studio make acquisition economically irrational. Most realistic play: watch.

Risk: Developer studio is inactive; no updates or engagement for 128 months, raising questions about ongoing IP stewardship, support obligations, and future content.
Risk: Extremely niche subject matter (child mortality from cancer) limits mainstream audience and resale/bundling appeal; high sensitivity risk if revival or marketing missteps occur.
Risk: Game is nine years old with no cloud save, achievements, or workshop support; technical debt and platform obsolescence risk over time.

This case as Markdown · Estimates carry ±30-50% error per title.